Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

PURPOSE To investigate the effect of the peptide NC-1059 on riboflavin (RF) diffusion across an intact corneal epithelium into the stroma. METHODS NC-1059 peptide was synthesized by solid-phase synthesis with 9-fluorenylmethoxycarbonyl chemistry, characterized by reversed-phase HPLC, and matrix-assisted laser desorption ionization time-of-flight mass spectroscopy. The diffusion of RF across embryonic day 18 chick corneal epithelium ex vivo was monitored using confocal microscopy. The depth distributions of RF in the corneal stroma were calculated using a group of linear equations based on the relationship between RF fluorescence intensity and concentration. RESULTS Data presented in this study demonstrate that the NC-1059 peptide can transiently open the intact epithelial barrier to allow the permeation of RF into the stroma. The effect of NC-1059 peptide on RF diffusion across the corneal epithelium was concentration and time dependent. The amount of RF reaching a 50-μm depth of chick corneal stoma increased dramatically after exposure to NC-1059 for 10 minutes, reaching a plateau by 30 minutes. The concentrations of RF in the presence of NC-1059 at corneal stromal depths of 50, 100, and 150 μm were significantly higher than in the absence of the peptide, and almost as high as in corneas in which the epithelium first had been physically removed. In addition, a cell viability assay indicated that the NC-1059 peptide did not kill corneal epithelial cells. CONCLUSIONS NC-1059 peptide significantly enhances the diffusion of RF across intact corneal epithelium into the stroma.

[1]  F. Raiskup,et al.  Correlation Between UV Absorption and Riboflavin Concentration in Different Depths of the Cornea in CXL , 2010, Current eye research.

[2]  L. Zimmerman,et al.  Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. , 1988, American journal of ophthalmology.

[3]  M. Kahook,et al.  Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells , 2010, Advances in therapy.

[4]  J. Alió,et al.  Microbial keratitis after corneal collagen crosslinking. , 2009, Journal of cataract and refractive surgery.

[5]  D. Musch,et al.  Extended long-term outcomes of penetrating keratoplasty for keratoconus. , 2006, Ophthalmology.

[6]  J. Marshall,et al.  Effect of complete epithelial debridement before riboflavin–ultraviolet‐A corneal collagen crosslinking therapy , 2008, Journal of cataract and refractive surgery.

[7]  A. J. Scott,et al.  Aqueous solubilization of transmembrane peptide sequences with retention of membrane insertion and function. , 1998, Biophysical journal.

[8]  A. Urtti,et al.  Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.

[9]  E. Spörl,et al.  Untersuchungen zur Verfestigung der Hornhaut am Kaninchen , 2000, Der Ophthalmologe.

[10]  N. Sharma,et al.  Pseudomonas keratitis after collagen crosslinking for keratoconus: case report and review of literature. , 2010, Journal of cataract and refractive surgery.

[11]  A. Mitra,et al.  Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. , 2007, International journal of pharmaceutics.

[12]  James S Wolffsohn,et al.  Keratoconus: a review. , 2010, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[13]  R. D. Lynch,et al.  The tight junction: a multifunctional complex. , 2004, American journal of physiology. Cell physiology.

[14]  S Reichl,et al.  Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.

[15]  F. Raiskup,et al.  Riboflavin Osmolar Modification for Transepithelial Corneal Cross-Linking , 2011, Current eye research.

[16]  H. Sasaki,et al.  Enhancement of ocular drug penetration. , 1999, Critical reviews in therapeutic drug carrier systems.

[17]  Kati-Sisko Vellonen,et al.  Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.

[18]  C. Baudouin,et al.  In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[19]  S. Klyce,et al.  Transport processes across the rabbit corneal epithelium: a review. , 1985, Current eye research.

[20]  G. Wollensak,et al.  Behandlung von Keratokonus durch Kollagenvernetzung , 2003, Der Ophthalmologe.

[21]  G. Conrad,et al.  Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking* , 2011, The Journal of Biological Chemistry.

[22]  H. Grossniklaus,et al.  The corneal epithelium after optisol-GS storage. , 1996, Cornea.

[23]  Joseph Colin,et al.  Intracorneal rings for keratoconus and keratectasia , 2007, Journal of cataract and refractive surgery.

[24]  D. Powell,et al.  Barrier function of epithelia. , 1981, The American journal of physiology.

[25]  P. Riesz,et al.  A STUDY OF THE PHOTODYNAMIC EFFICIENCIES OF SOME EYE LENS CONSTITUENTS , 1991, Photochemistry and photobiology.

[26]  G. Conrad,et al.  Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). , 2010, Investigative ophthalmology & visual science.

[27]  G. Conrad,et al.  The role of nonenzymatic glycation and carbonyls in collagen cross-linking for the treatment of keratoconus. , 2011, Investigative ophthalmology & visual science.

[28]  G. Snibson,et al.  Collagen cross‐linking: a new treatment paradigm in corneal disease – a review , 2010, Clinical & experimental ophthalmology.

[29]  Munish Sharma,et al.  Effect of inferior‐segment Intacs with and without C3‐R on keratoconus , 2007, Journal of cataract and refractive surgery.

[30]  L. Drolsum,et al.  Penetration of riboflavin and postoperative pain in corneal collagen crosslinking: Excimer laser superficial versus mechanical full‐thickness epithelial removal , 2009, Journal of cataract and refractive surgery.

[31]  T. Iwamoto,et al.  Channel-forming peptide modulates transepithelial electrical conductance and solute permeability. , 2004, American journal of physiology. Cell physiology.

[32]  T. Iwamoto,et al.  NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium. , 2009, Investigative ophthalmology & visual science.

[33]  M. Kasper,et al.  [Increased rigidity of the cornea caused by intrastromal cross-linking]. , 1997, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[34]  G. Wollensak,et al.  Crosslinking treatment of progressive keratoconus: new hope , 2006, Current opinion in ophthalmology.

[35]  E. Spoerl,et al.  Induction of cross-links in corneal tissue. , 1998, Experimental eye research.

[36]  A. Ivarsen,et al.  Corneal Distribution of Riboflavin Prior to Collagen Cross-Linking , 2009, Current eye research.

[37]  T. Seiler,et al.  Endothelial cell damage after riboflavin–ultraviolet‐A treatment in the rabbit , 2003, Journal of cataract and refractive surgery.

[38]  G. Wollensak,et al.  Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement , 2009, Journal of cataract and refractive surgery.

[39]  Hong Liang,et al.  Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines , 2008, Molecular vision.

[40]  A. Chvátal,et al.  Quantification of astrocyte volume changes during ischemia in situ reveals two populations of astrocytes in the cortex of GFAP/EGFP mice , 2009, Journal of neuroscience research.

[41]  T. Seiler,et al.  Laboratory measurement of the absorption coefficient of riboflavin for ultraviolet light (365 nm). , 2010, Journal of refractive surgery.

[42]  H. Edelhauser,et al.  The role of thyroid hormone in the development of the chick corneal endothelium and epithelium. , 1977, Investigative ophthalmology & visual science.

[43]  B. Pogue,et al.  Fluorophore quantitation in tissue-simulating media with confocal detection , 1996 .

[44]  C. Kim,et al.  Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro , 2004, Clinical & experimental ophthalmology.

[45]  J. Alió,et al.  Contact lens fitting in keratoconus. , 2006, Comprehensive ophthalmology update.

[46]  G. Feldmann,et al.  Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. , 1999, Investigative ophthalmology & visual science.

[47]  S. Klyce Electrical profiles in the corneal epithelium , 1972, The Journal of physiology.

[48]  Farhad Hafezi,et al.  Corneal Cross-Linking-Induced Stromal Demarcation Line , 2006, Cornea.

[49]  M. Kahook,et al.  Comparison of Corneal and Conjunctival Changes After Dosing of Travoprost Preserved With sofZia, Latanoprost With 0.02% Benzalkonium Chloride, and Preservative-free Artificial Tears , 2008, Cornea.

[50]  F. Raiskup,et al.  Pharmacological Modification of the Epithelial Permeability by Benzalkonium Chloride in UVA/Riboflavin Corneal Collagen Cross-Linking , 2010, Current eye research.

[51]  R. Pineda,et al.  Corneal Cross Linking for Keratoconus , 2010, Seminars in ophthalmology.

[52]  C. Cursiefen,et al.  Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. , 2009, Journal of cataract and refractive surgery.

[53]  F. X. Yu,et al.  Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. , 2000, Investigative ophthalmology & visual science.

[54]  J. Marshall,et al.  Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. , 2009, Journal of refractive surgery.

[55]  T. Iwamoto,et al.  Epithelial Barrier Modulation by a Channel Forming Peptide , 2008, Journal of Membrane Biology.

[56]  D. Tan,et al.  Current treatment options for corneal ectasia , 2007, Current opinion in ophthalmology.

[57]  P. Friedl,et al.  Influence of corneal collagen crosslinking with riboflavin and ultraviolet-a irradiation on excimer laser surgery. , 2010, Investigative ophthalmology & visual science.

[58]  M. Abelson,et al.  Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. , 1992, Archives of ophthalmology.

[59]  S. Kinoshita,et al.  Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium. , 2009, Investigative ophthalmology & visual science.

[60]  J. Revel,et al.  Fine structure of the developing avian cornea. , 1969, Monographs in developmental biology.

[61]  T. Iwamoto,et al.  Distinct structural elements that direct solution aggregation and membrane assembly in the channel-forming peptide M2GlyR. , 2002, Biochemistry.

[62]  S. Dey Corneal cell culture models: a tool to study corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.

[63]  P. Lwigale Nuclear Morphologies of Bovine Corneal Cells as Visualized by Confocal Microscopy , 1999, Cells Tissues Organs.

[64]  Wayne H Knox,et al.  High-resolution, noninvasive, two-photon fluorescence measurement of molecular concentrations in corneal tissue. , 2011, Investigative ophthalmology & visual science.